By Patrick Rüdelsheim
We have compiled a biosafety guidance document specifically for life science laboratories in Belgium that have been asked to contribute to SARS-CoV-2 diagnostics. While these organisations may have adequate technical capacities, they may not have experience with diagnostics of high-risk pathogens. We make this guidance available, free of charge, for such organisations linked with an interactive service to ensure that we can address emerging questions and keep the guidance up-to-date.
(No Ratings Yet)
Loading...
